We welcome submissions from researchers, clinicians, academicians, trialists, and regulatory professionals whose work contributes to the advancement of clinical research. To ensure a smooth and efficient publication process, authors are advised to carefully review and follow the guidelines below before submitting their manuscript to the SCICONX Journal of Clinical Trials.

✦ Manuscript Types Accepted:

• Original Research Articles
• Clinical Trial Protocols
• Systematic Reviews and Meta-Analyses
• Brief Reports / Pilot Studies
• Case Series / Case Reports
• Methodological Papers
• Perspective and Commentary
• Regulatory & Ethical Analyses
• Editorials

✦ Manuscript Preparation

 General Format

• Formatting Template (Please click here to download.)
• File type: Microsoft Word (.doc or .docx)
• Font: Times New Roman, 12 pt
• Line spacing: Double
• Margins: 1 inch (2.54 cm) on all sides
• Page numbers: Bottom-right corner

Manuscript Structure

• Title Page
  • Title of the manuscript
  • Author(s) full name, affiliation, email
  • Corresponding author’s contact details
  • Trial registration number (if applicable)
• Abstract (250–300 words)
  • Structured format: Background, Methods, Results, Conclusion
  • Include 4–6 keywords
• Main Text
  • Original Articles: Introduction, Methods, Results, Discussion, Conclusion
  • Other formats should follow discipline-specific structures
• Acknowledgments
  • Funding sources, institutional support, contributors, etc.
• References
  • Use Vancouver style. Cite using superscript numbers in the order of appearance.
• Figures & Tables
  • High-resolution (300 dpi) images
  • Tables editable in Word, not as images
  • Each figure/table should be referenced in the text and submitted separately as supplementary files.

✦ Clinical Trial Registration

All interventional clinical trials must be prospectively registered in a public trial registry (e.g., ClinicalTrials.gov). The registration ID should be included in the abstract and methods section.

✦ Ethical Compliance

Manuscripts involving human participants must include a statement of approval from an appropriate ethics committee and confirmation of informed consent. For vulnerable populations, additional safeguards must be detailed.

✦ Submission Process

For submission of your manuscript, please visit the Submit Manuscript page

All submissions undergo a double-blind peer review process. Authors are required to suggest at least two potential reviewers (not from the same institution).

⏱️ Review & Publication Timeline

• Initial Editorial Decision: ~7 days
• Peer Review Completion: ~14 - 21 days
• Online Publication (post-acceptance): ~7–10 days

✦ Article Processing Charges (APCs)

The SCICONX Journal of Clinical Trials operates under an open-access model. APC details will be communicated upon acceptance.

✦ Contact for Submission Queries

If you have any questions about the submission guidelines or manuscript preparation, please contact editor.clinicaltrials@sciconxjournals.com

By submitting to the SCICONX Journal of Clinical Trials, authors confirm that the manuscript is original, not under consideration elsewhere, and complies with all ethical and scientific integrity standards.